By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Celera today said that it will file an extension to delay filing its Form 10-K with the US Securities and Exchange Commission, and it has postponed its fourth-quarter and fiscal-year 2010 conference call, which was scheduled for later today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.